Loading stock…

Bank Hapoalim B.M. (POLI) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

POLIBank Hapoalim B.M.

Revenue FY25$7.3B

GROWTH RATING↗

——

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%–

Revenue, next 1Yna–

Revenue, next 3Y, CAGR+6%–

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-3%3

EPS growth, FY27E+19%8

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 6%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 13%/yr over the last 3 years; forecasts see it cooling to 6%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

Earnings are set to grow in step with sales (EPS about 11%/yr vs revenue 6%/yr). One year dips: EPS falls 3% next year.

WEAKNESSES

Growth is the weak spot here, trailing 100% of companies worldwide.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

POLIBank Hapoalim B.M.

Total return Current424%

Price return Current316%

MOMENTUM RATING↗

STRONG82 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return+9%8

YTD return+9%6

MID & LONG-TERM▾SCORE

% of 52-week high91%8

1-year return+21%7

3-year return+155%9

5-year return+231%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +155% over three years and +231% over five, ahead of 80% of the market.

It's up 21% over the past year, but 9% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+9%).

WATCH

Returns sit at the market level over the past month (-6%) and so far this year (+9%).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Compounder

Dependable multi-year returns and the stock sits near its highs. A reliable trend, if not the single hottest name in the market.

04Value

Are you paying a fair price for it?

Stop guessing on Hapoalim. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

POLIBank Hapoalim B.M.

Revenue FY25$7.3B

GROWTH RATING↗

——

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%–

Revenue, next 1Yna–

Revenue, next 3Y, CAGR+6%–

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-3%3

EPS growth, FY27E+19%8

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 6%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 13%/yr over the last 3 years; forecasts see it cooling to 6%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

Earnings are set to grow in step with sales (EPS about 11%/yr vs revenue 6%/yr). One year dips: EPS falls 3% next year.

WEAKNESSES

Growth is the weak spot here, trailing 100% of companies worldwide.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

POLIBank Hapoalim B.M.

Total return Current424%

Price return Current316%

MOMENTUM RATING↗

STRONG82 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return+9%8

YTD return+9%6

MID & LONG-TERM▾SCORE

% of 52-week high91%8

1-year return+21%7

3-year return+155%9

5-year return+231%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +155% over three years and +231% over five, ahead of 80% of the market.

It's up 21% over the past year, but 9% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+9%).

WATCH

Returns sit at the market level over the past month (-6%) and so far this year (+9%).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Compounder

Dependable multi-year returns and the stock sits near its highs. A reliable trend, if not the single hottest name in the market.

04Value

Are you paying a fair price for it?

Stop guessing on Hapoalim. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Bank Hapoalim B.M.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Hapoalim. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Hapoalim. Get the full investment case.

Premium